- call +1-201-465-4211
- email sales@mrinsights.biz
A lower GI series is a procedure in which a doctor uses x-rays and a chalky liquid called bariumto view your large intestine. The barium will make your large intestine more visible on an x-ray. The two types of lower GI series are a single-contrast lower GI series, which uses only barium and a double-contrast or air-contrast lower GI series, which uses both barium and air for a clearer view of your large intestine.
Scope of the Report:
This report studies the Lower GI Series market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lower GI Series market by product type and applications/end industries.
A lower GI series can help a doctor find the cause of bleeding from anus, changes in bowel activity, chronic diarrhea, pain in abdomen and unexplained weight loss.
The global Lower GI Series market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lower GI Series.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Eisai
Cadila Pharmaceuticals
Purdue Pharma
Peacehealth
Novadaq
Astrazeneca
Ironwood Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Double-Contrast
Single-Contrast
Market Segment by Applications, can be divided into
Gastroenteritis
Colon Polyps
Tumor
Strictures Crohn's Disease
Ulcerative Colitis
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Lower GI Series Market Overview
1.1 Product Overview and Scope of Lower GI Series
1.2 Classification of Lower GI Series by Types
1.2.1 Global Lower GI Series Revenue Comparison by Types (2017-2023)
1.2.2 Global Lower GI Series Revenue Market Share by Types in 2017
1.2.3 Double-Contrast
1.2.4 Single-Contrast
1.3 Global Lower GI Series Market by Application
1.3.1 Global Lower GI Series Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Gastroenteritis
1.3.3 Colon Polyps
1.3.4 Tumor
1.3.5 Strictures Crohn's Disease
1.3.6 Ulcerative Colitis
1.3.7 Others
1.4 Global Lower GI Series Market by Regions
1.4.1 Global Lower GI Series Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Lower GI Series Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Lower GI Series Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lower GI Series Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Lower GI Series Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lower GI Series Status and Prospect (2013-2023)
1.5 Global Market Size of Lower GI Series (2013-2023)
2 Manufacturers Profiles
2.1 Eisai
2.1.1 Business Overview
2.1.2 Lower GI Series Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eisai Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.2 Cadila Pharmaceuticals
2.2.1 Business Overview
2.2.2 Lower GI Series Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cadila Pharmaceuticals Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.3 Purdue Pharma
2.3.1 Business Overview
2.3.2 Lower GI Series Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Purdue Pharma Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.4 Peacehealth
2.4.1 Business Overview
2.4.2 Lower GI Series Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Peacehealth Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novadaq
2.5.1 Business Overview
2.5.2 Lower GI Series Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novadaq Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.6 Astrazeneca
2.6.1 Business Overview
2.6.2 Lower GI Series Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Astrazeneca Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ironwood Pharmaceuticals
2.7.1 Business Overview
2.7.2 Lower GI Series Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ironwood Pharmaceuticals Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
3 Global Lower GI Series Market Competition, by Players
3.1 Global Lower GI Series Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Lower GI Series Players Market Share
3.2.2 Top 10 Lower GI Series Players Market Share
3.3 Market Competition Trend
4 Global Lower GI Series Market Size by Regions
4.1 Global Lower GI Series Revenue and Market Share by Regions
4.2 North America Lower GI Series Revenue and Growth Rate (2013-2018)
4.3 Europe Lower GI Series Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Lower GI Series Revenue and Growth Rate (2013-2018)
4.5 South America Lower GI Series Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Lower GI Series Revenue and Growth Rate (2013-2018)
5 North America Lower GI Series Revenue by Countries
5.1 North America Lower GI Series Revenue by Countries (2013-2018)
5.2 USA Lower GI Series Revenue and Growth Rate (2013-2018)
5.3 Canada Lower GI Series Revenue and Growth Rate (2013-2018)
5.4 Mexico Lower GI Series Revenue and Growth Rate (2013-2018)
6 Europe Lower GI Series Revenue by Countries
6.1 Europe Lower GI Series Revenue by Countries (2013-2018)
6.2 Germany Lower GI Series Revenue and Growth Rate (2013-2018)
6.3 UK Lower GI Series Revenue and Growth Rate (2013-2018)
6.4 France Lower GI Series Revenue and Growth Rate (2013-2018)
6.5 Russia Lower GI Series Revenue and Growth Rate (2013-2018)
6.6 Italy Lower GI Series Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Lower GI Series Revenue by Countries
7.1 Asia-Pacific Lower GI Series Revenue by Countries (2013-2018)
7.2 China Lower GI Series Revenue and Growth Rate (2013-2018)
7.3 Japan Lower GI Series Revenue and Growth Rate (2013-2018)
7.4 Korea Lower GI Series Revenue and Growth Rate (2013-2018)
7.5 India Lower GI Series Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Lower GI Series Revenue and Growth Rate (2013-2018)
8 South America Lower GI Series Revenue by Countries
8.1 South America Lower GI Series Revenue by Countries (2013-2018)
8.2 Brazil Lower GI Series Revenue and Growth Rate (2013-2018)
8.3 Argentina Lower GI Series Revenue and Growth Rate (2013-2018)
8.4 Colombia Lower GI Series Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Lower GI Series by Countries
9.1 Middle East and Africa Lower GI Series Revenue by Countries (2013-2018)
9.2 Saudi Arabia Lower GI Series Revenue and Growth Rate (2013-2018)
9.3 UAE Lower GI Series Revenue and Growth Rate (2013-2018)
9.4 Egypt Lower GI Series Revenue and Growth Rate (2013-2018)
9.5 Nigeria Lower GI Series Revenue and Growth Rate (2013-2018)
9.6 South Africa Lower GI Series Revenue and Growth Rate (2013-2018)
10 Global Lower GI Series Market Segment by Type
10.1 Global Lower GI Series Revenue and Market Share by Type (2013-2018)
10.2 Global Lower GI Series Market Forecast by Type (2018-2023)
10.3 Double-Contrast Revenue Growth Rate (2013-2023)
10.4 Single-Contrast Revenue Growth Rate (2013-2023)
11 Global Lower GI Series Market Segment by Application
11.1 Global Lower GI Series Revenue Market Share by Application (2013-2018)
11.2 Lower GI Series Market Forecast by Application (2018-2023)
11.3 Gastroenteritis Revenue Growth (2013-2018)
11.4 Colon Polyps Revenue Growth (2013-2018)
11.5 Tumor Revenue Growth (2013-2018)
11.6 Strictures Crohn's Disease Revenue Growth (2013-2018)
11.7 Ulcerative Colitis Revenue Growth (2013-2018)
11.8 Others Revenue Growth (2013-2018)
12 Global Lower GI Series Market Size Forecast (2018-2023)
12.1 Global Lower GI Series Market Size Forecast (2018-2023)
12.2 Global Lower GI Series Market Forecast by Regions (2018-2023)
12.3 North America Lower GI Series Revenue Market Forecast (2018-2023)
12.4 Europe Lower GI Series Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Lower GI Series Revenue Market Forecast (2018-2023)
12.6 South America Lower GI Series Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Lower GI Series Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Lower GI Series Picture
Table Product Specifications of Lower GI Series
Table Global Lower GI Series and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
